Concepedia

Author

Irida Kastrati

University of Illinois ChicagoORCID

Also Known As

I Kastrati, I. Kastrati, Irida Kastrati, Irida. Kastrati (7976906)

78

Publications

985

Citations

16

H-Index

36

Concepts

All Affiliations

University of Illinois ChicagoInstitute of Molecular Biology and BiophysicsLoyola University ChicagoScripps Research InstituteUniversity of California San Diego
IK

About

Irida Kastrati is an author at University of Illinois Chicago specializing in medicine, breast cancer, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

476

2

Cell Biology

3

3

311

3

Natural Sciences

1

1

43

4

Public Health

1

1

21

5

Chemistry

1

1

43

Irida Kastrati

×

17

Publications

818

Citations

14

H-Index

YearCitations

Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein

Irida Kastrati, Marton I. Siklos, Esther L. Calderon-Gierszal,

Journal of Biological Chemistry

2015

140

Benzothiophene Selective Estrogen Receptor Modulators with Modulated Oxidative Activity and Receptor Affinity

Zhihui Qin, Irida Kastrati, R. Esala P. Chandrasena,

Journal of Medicinal Chemistry

2007

137

Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells

Joshua D. Stender, J.C. Nwachukwu, Irida Kastrati,

Molecular Cell

2017

115

The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers

Irida Kastrati, Stacey E. P. Joosten, Svetlana E. Semina,

Molecular Cancer Research

2020

61

Full antagonism of the estrogen receptor without a prototypical ligand side chain

Sathish Srinivasan, J.C. Nwachukwu, Nelson E. Bruno,

Nature Chemical Biology

2016

60

PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres

Irida Kastrati, Emanuele Canestrari, Jonna Frasor

Oncogene

2014

56

Structure–Activity Relationships for a Family of Benzothiophene Selective Estrogen Receptor Modulators Including Raloxifene and Arzoxifene

Cassia Overk, Kuan‐Wei Peng, Rezene T. Asghodom,

ChemMedChem

2007

43

Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer

Lamiaa El-Shennawy, Oleksii Dubrovskyi, Irida Kastrati,

Cancer Research

2017

38

SELENOF is a new tumor suppressor in breast cancer

Alexandra Zigrossi, Lenny K. Hong, Roudy Chiminch Ekyalongo,

Oncogene

2022

30

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms

Bolan Yu, Birgit M. Dietz, Tareisha L. Dunlap,

Molecular Cancer Therapeutics

2007

25

Page 1